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Introduction
Pancreatic cancer is the fourth leading cause of cancer-related death in the US (1) (2) (3) . At the time of diagnosis more than 80% of patients have locally advanced or metastatic disease. The late diagnosis, disease aggression, and scarcity of treatment options combine to give a median survival time of 6 months, and a 5-year survival rate of less than 5% (2, 4) . Cancer of the exocrine duct cells (pancreatic ductal adenocarcinoma, PDA) constitutes 90% of pancreatic cancers (5).
Mutations and/or deletions in oncogenes and tumor suppressor genes are common in PDA. As for many cancers, the genes most affected lie in pathways that control the cell cycle; they include Kras, p16/CDKN2A, p53, SMAD4/DPC4, and BRCA2 (6, 7) . Our knowledge of the events that initiate and promote tumor growth in pancreatic cancer has increased, but the precise molecular signature remains incomplete. A better understanding of the earliest carcinogenetic events is required to develop tools for earlier diagnosis, and to identify novel candidate molecules for targeted therapies.
The inhibitor of differentiation (Id) proteins are transcriptional regulators with critical roles in normal cell growth and differentiation (8, 9) . The primary function of the four Id proteins (Id1-Id4) is to bind to and inhibit the activity of basic helix-loop-helix (bHLH) transcription factors, e.g. E47 (10) . The bHLH proteins activate transcription by forming homodimers or heterodimers that bind to regulatory 'E-box' DNA sequences in target genes. Id proteins lack the basic DNA-binding domains, and form non-functional prognostic factors for some cancers, providing further impetus to understand the role played by Id proteins in tumorigenesis and tumor growth (19) .
In the present study, we have investigated the role of Id3 in cell cycle control of normal and pathogenic ductal cells. We identify high Id3 expression as an early event in pancreatitis and pancreatic intraepithelial neoplasia (PanIN) formation and a prominent characteristic of human PDA. In primary cells we demonstrate that Id3 is sufficient to induce cell cycle entry in quiescent human pancreatic ductal cells. We further demonstrate a functional requirement for Id3 in proliferation of PDA cells. Growth arrest can be induced in PDA cells by altering the balance of bHLH/Id proteins either by knockdown of Id3 or by overexpression of E47. The results support the hypothesis that Id3 expression plays a key role in pancreatic tumorigenesis and suggest that restoring the balance of the Id3/E47 axis is a promising therapeutic approach to PDA.
Results

Id3 is highly expressed in hyperplastic ducts in pancreatitis.
To determine whether the Id family of proteins plays an early role in the pathological growth of pancreatic exocrine tissue, we examined Id protein expression in a rapid model of pancreatitis. Normal murine pancreatic ducts are quiescent and do not incorporate BrdU (20) . Ligation of the main pancreatic duct (PDL) induces pancreatitis reveal a temporal and spatial link between Id3 and the onset of duct hyperplasia consistent with a role for Id3 in the initiation of pancreatitis.
Examination of the remaining Id family members revealed that Id2 and Id4 expression also increased in hyperplastic ducts following PDL, but the staining pattern suggested a diffuse subcellular distribution, rather than nuclear expression. PDL did not affect the expression of Id1 (Fig. 1A-L) . (Fig. 2C-F , and Supp. Fig. 2 ). In contrast, Id3 was only weakly detectable in the exocrine pancreas of control Pdx-1-cre mice ( Fig. 2A, B and Supp. Fig.   2 ). The data reveal that Id3 is expressed throughout PDA disease progression, suggesting that Id3 plays a role in pancreatic carcinogenesis.
Id3 is expressed in murine
Upregulation of mRNA and protein from Id family members has been detected in various human cancers (25) (26) (27) . However, Id3 expression in human PDA has been controversial, and the precise contribution made by Id3 to cell proliferation and differentiation in human PDA is unknown (28-29). To address this question, and to extend the relevance of our observations to human disease, we analyzed Id3 expression in human PDA tissues. Id3 protein was weakly expressed or undetectable in normal, non-neoplastic areas of exocrine tissue (Fig. 2G, H , and Supp. Fig. 3 ). In contrast, prominent Id3 staining was observed in the majority of cytokeratin 19 (CK19) positive ductal cells within neoplastic tissue areas (Fig. 2I-L and Supp. Fig. 3 ), confirming that Id3 expression in the human exocrine pancreas is associated with PDA.
Id3 and E47 regulate the cell cycle in human PDA cells
To determine whether Id3 is functionally involved in cell proliferation in PDA we examined the effects of Id3 depletion in the human pancreatic cancer cell line Panc-1 (30) . Transfection with a short interfering RNA (siRNA) sequence specific for Id3 inhibited Id3 mRNA by 57% (Supp. Fig. 4 ). Id3 knockdown resulted in a marked reduction in BrdU incorporation in Panc-1 cells, demonstrating that Id3 activity is required for DNA synthesis of human PDA cells (Fig. 3A-E) . Interestingly, Panc-1 cell growth is also reportedly inhibited by Id2 antisense treatment (25) .
Id proteins inhibit cellular differentiation and stimulate proliferation by blocking the activity of DNA-binding bHLH regulatory proteins (8, 13) , We and others have shown that bHLH transcription factors are essential mediators of cell fate in pancreatic tissue (31) (32) . Moreover, we recently demonstrated that the bHLH protein E47 causes growth arrest in a cell line developed from human fetal pancreatic tissue (33) .
Our working model predicted that Id3 promotes PDA growth by inhibiting bHLH protein activity. Thus, we reasoned that enforced ectopic expression of the bHLH protein E47 should shift the Id3/E47 balance, and suppress proliferation of human PDA cells. To test this hypothesis, Panc-1 was engineered to stably express an inducible form of the E47.
Here, the E47 protein was fused with a modified estrogen receptor (E47 MER ), which rendered it sensitive to the estrogen analog tamoxifen (33, 34) . 
Discussion
Dysregulated expression of Id proteins has been noted in a variety of cancers, and this has prompted interest in Id proteins as both diagnostic markers and as potential therapeutic targets (37) . In the present study, we hypothesized that Id3 plays both early and sustained roles in pathogenic pancreatic duct cell growth. Our results are consistent with this hypothesis, and strongly suggest that Id3 activity contributes to the pronounced growth that is a hallmark of pancreatic ductal adenocarcinoma (PDA).
To test the hypothesis that Id3 expression and duct hyperplasia are temporally and In contrast to Id3, Id1 was present in pancreatic tissue at low to moderate levels but the expression was not affected by PDL. Id2 and Id4 expression increased after PDL, but the staining patterns were diffuse, in contrast to the nuclear staining of Id3. One study examining Id mRNA and protein expression in pancreatic tissue from chronic pancreatitis (CP) patients (26) noted that Id mRNA levels were similar in CP and normal pancreas but that Id1, Id2, and Id3 proteins were more highly expressed in dysplastic pancreatic ducts than in normal tissue. This latter finding is similar but not identical to our observations in murine pancreatitis. 
of Id1, Id2, and Id3 expression in human PDA tissue (42, (25) (26) (27) (28) (29) . In one study, slightly increased Id3 in PDA tissues was observed compared with normal pancreas. However, they observed moderate and occasionally strong staining of Id3 expression in normal pancreas, which we did not see (26) In a previous study we demonstrated that normally quiescent human pancreatic duct cells were not efficiently stimulated to proliferate in response to high serum or growth factors (35) . The observation that Id3 expression was elevated in even the earliest 
Human cells and tissue
The For analysis of pancreatic duct ligation (PDL), tissue proximal and distal to the ligature was harvested 7 days following surgery and fixed in 4% paraformaldehyde (USB, OH) for 16-18hr at 4°C followed by freezing in OCT embedding media (Sakura Finetek, CA). Pancreata from Pdx-1-cre;LSL-Kras G12D mice and control Pdx-1-cre mice were harvested and paraffin embedded using standard procedures as previously described (23) . All tissue samples were sectioned to a mean thickness of 5µm. Cultured Panc-1 and Panc-1/E47 mer cells and primary human exocrine cells were fixed in 4% paraformaldehyde (USB, OH) for 15min at 4°C.
All samples were permeabilized with 0.3% Triton X-100 in PBS for 15min and blocked for 1hr at room temperature. Cells were incubated with the following primary antibodies overnight at 4°C: 
Statistical analyses
Data are presented as means±SEM. The statistical significance of the differences between groups was analyzed by Student's t test. Monolayer cultures of human pancreatic duct cells were infected with an adenoviral vector expressing Id3.
Immunofluorescence revealed that only Id3 positive cells (green) express the S-phase marker pCycineE (red).
Blue nuclear counterstain is DAPI. Scale bars, 25μm. 
